Three former executives at Archer-Daniels-Midland (ADM) intentionally misled investors by inflating the performance of the company’s Nutrition unit, the Securities and Exchange Commission (SEC) has alleged.

Adrianne Appel writes regulatory news, policy, and trends for Compliance Week. She previously reported about policy developments for Bloomberg Law and Bloomberg Government. Email: adrianne.appel@complianceweek.com LinkedIn:...